Medios AG

Chart & Performance

D1W1MN

P/E

19.92

P/S

0.15

EPS

0.60

Div Yield, %

—

Shrs. gr., 5y

9.37%

Rev. gr., 5y

27.11%

Revenues

2.08b

+10.39%

Net income

15m

+22.45%

CFO

43m

-41.62%

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Profile

Medios AG is a holding company, which engages in the provision of pharmaceutical drugs. It operates through the following segments: Pharmaceutical Supply, Patient-Specific Therapies, and Services. The Pharmaceutical Supply segment focuses on specialty pharmaceuticals for chronic and/or rare diseases. The Patient-Specific Therapies segment involves in the manufacturing of medications. The Services segment consists of the Groups other activities. The company was founded in 1980 and is headquartered in Berlin, Germany.

URL

https://medios.ag/

IPO date

Jan 01, 1999

Employees

514

Domiciled in

Incorporated in

Valuation

Order:

Title EUR in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title EUR in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT